Trial · NCT01330134
Comparison of Two Lidocaine Administration Techniques
NCT01330134, Phase 4, Completed, University of Chicago; results first posted 2018-06-28
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Comparison of Two Lidocaine Administration Techniques. Trials, record NCT01330134. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01330134
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparison of Two Lidocaine Administration Techniques
- NCT number
- NCT01330134
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 481 participants, actual
- Lead sponsor
- University of Chicago
- Conditions
- Pain
- Interventions
- lidocaine, lidocaine
- First posted
- 2011-04-06
- Last updated
- 2018-07-26
- Results first posted
- 2018-06-28
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Pain Assessment: Overall | post procedure (day 1) | Visual analog scale (VAS). This is a standardized analog scale with scores from 0-100. It measures level of pain with 0 meaning no pain and 100 meaning the most extreme level of pain. Higher values refer to a worse outcome. |
| Secondary | Pain Assessment: Lidocaine Injection | post procedure (day 1) | visual analog scale (VAS) 0= no pain to 100 = worse pain possible |
| Secondary | Pain Assessment: During Procedure | post procedure (day 1) | visual analog scale (VAS) 0 = no pain to 100 = worse pain possible Rather, this is a pain assessment during the actual procedure rather than during the pre-procedure lidocaine injection. |
Source ClinicalTrials.gov
Outcomes3
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Pain Assessment: Overall | post procedure (day 1) | units on a scale | MEAN | |
| SECONDARY | Pain Assessment: Lidocaine Injection | post procedure (day 1) | units on a scale | MEAN | |
| SECONDARY | Pain Assessment: During Procedure | post procedure (day 1) | units on a scale | MEAN |
Source ClinicalTrials.gov
Results by group6
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Pain Assessment: Overall | Lidocaine Onto Skin Prior to Lidocaine Subcutaneous Injection | 15.3 | Standard Deviation 19.3 | units on a scale | |
| Pain Assessment: Overall | Lidocaine Subcutaneous Injection Alone | 19.0 | Standard Deviation 22.8 | units on a scale | |
| Pain Assessment: Lidocaine Injection | Lidocaine Onto Skin Prior to Lidocaine Subcutaneous Injection | 18.4 | Standard Deviation 21.2 | units on a scale | |
| Pain Assessment: Lidocaine Injection | Lidocaine Subcutaneous Injection Alone | 20.8 | Standard Deviation 23.5 | units on a scale | |
| Pain Assessment: During Procedure | Lidocaine Onto Skin Prior to Lidocaine Subcutaneous Injection | 12.2 | Standard Deviation 19.4 | units on a scale | |
| Pain Assessment: During Procedure | Lidocaine Subcutaneous Injection Alone | 16.6 | Standard Deviation 24.8 | units on a scale |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Lidocaine Onto Skin Prior to Lidocaine Subcutaneous Injection | 244 | |
| Overall Study | STARTED | Lidocaine Subcutaneous Injection Alone | 237 | |
| Overall Study | COMPLETED | Lidocaine Onto Skin Prior to Lidocaine Subcutaneous Injection | 244 | |
| Overall Study | COMPLETED | Lidocaine Subcutaneous Injection Alone | 237 | |
| Overall Study | NOT COMPLETED | Lidocaine Onto Skin Prior to Lidocaine Subcutaneous Injection | 0 | |
| Overall Study | NOT COMPLETED | Lidocaine Subcutaneous Injection Alone | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Lidocaine Onto Skin Prior to Lidocaine Subcutaneous Injection | 0 | 244 |
| Total, all-cause mortality | Lidocaine Subcutaneous Injection Alone | 0 | 237 |
| Total, other adverse events | Lidocaine Onto Skin Prior to Lidocaine Subcutaneous Injection | 0 | 244 |
| Total, other adverse events | Lidocaine Subcutaneous Injection Alone | 0 | 237 |
| Total, serious adverse events | Lidocaine Onto Skin Prior to Lidocaine Subcutaneous Injection | 0 | 244 |
| Total, serious adverse events | Lidocaine Subcutaneous Injection Alone | 0 | 237 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 29698720 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Lidocaine Onto Skin Prior to Lidocaine Subcutaneous Injection vs Lidocaine Subcutaneous Injection Alone: deaths from any cause | Trial comparisons |
| Lidocaine Onto Skin Prior to Lidocaine Subcutaneous Injection vs Lidocaine Subcutaneous Injection Alone: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01330134
GET https://conductscience.org/api/trials/v1/NCT01330134/registered